Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2303767
Max Phase: Preclinical
Molecular Formula: C21H24O9
Molecular Weight: 420.41
Molecule Type: Small molecule
Associated Items:
ID: ALA2303767
Max Phase: Preclinical
Molecular Formula: C21H24O9
Molecular Weight: 420.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)COc1cccc(-c2cccc(CO[C@H]3O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]3O)c2)c1
Standard InChI: InChI=1S/C21H24O9/c22-9-16-18(25)19(26)20(27)21(30-16)29-10-12-3-1-4-13(7-12)14-5-2-6-15(8-14)28-11-17(23)24/h1-8,16,18-22,25-27H,9-11H2,(H,23,24)/t16-,18-,19-,20+,21+/m1/s1
Standard InChI Key: BRJFNCPUWJLFEC-JFHUYLGKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 420.41 | Molecular Weight (Monoisotopic): 420.1420 | AlogP: 0.13 | #Rotatable Bonds: 8 |
Polar Surface Area: 145.91 | Molecular Species: ACID | HBA: 8 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.84 | CX Basic pKa: | CX LogP: 0.40 | CX LogD: -2.84 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.40 | Np Likeness Score: 0.75 |
1. Dupre B, Bui H, Scott IL, Market RV, Keller KM, Beck PJ, Kogan TP. (1996) Glycomimetic selectin inhibitors: (-D-mannopyranosyloxy)methylbiphenyls, 6 (5): [10.1016/0960-894X(96)00071-6] |
Source(1):